Better Value & Growth: COHR Leads Celestica Stock

CLS: Celestica logo
CLS
Celestica

COHR is Celestica’s peer in Electronic Components industry that has:

1) Lower valuation (P/OpInc) compared to Celestica stock
2) But higher revenue and operating income growth

This disconnect between valuation and performance could mean that you are better off buying COHR stock vs. CLS stock

Is holding CLS stock risky? Of course it is. High Quality Portfolio mitigates that risk.

Relevant Articles
  1. What’s Behind The 86% Surge in Wheaton Stock?
  2. Why Has Barrick Mining Stock Surged 154%?
  3. What Could Send Pfizer Stock Soaring
  4. What Can Trigger Intel Stock’s Slide?
  5. Cash Machine Trading Cheap – Iridium Communications Stock Set to Run?
  6. 3M Stock vs. Honeywell Stock: Which Is A Better Investment?

Key Metrics Compared

Metric CLS COHR
P/OpInc* 39.3x 39.0x
LTM OpInc Growth 96.3% 334.3%
3Y Avg OpInc Growth 60.5% 101.4%
LTM Revenue Growth 22.1% 23.4%
3Y Avg Revenue Growth 18.9% 23.4%

OpInc = Operating Income, P/OpInc = Price To Operating Income Ratio

But do these numbers tell the full story? Read Buy or Sell CLS Stock to see if Celestica still has an edge that holds up under the hood. As a quick background, Celestica (CLS) provides hardware platform and supply chain solutions, specializing in advanced technology, connectivity, cloud solutions, and enterprise-level data communications and information processing infrastructure products globally.

This is just one approach to evaluate investments. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure

Is The Mismatch In Stock Price Temporary

One way to check if Celestica stock is expensive now versus the other tickers would be to see how these metrics compared across companies exactly a year ago. Specifically, if there has been a marked reversal in the trend for Celestica in the last 12 months, then there is a chance that the current mismatch is likely to reverse. On the other hand, a persistent underperformance in revenue and operating income growth for Celestica would reinforce the conclusion that the stock is expensive compared to its peers, but may not revert soon

Key Metrics Compared 1 Yr Prior

Metric CLS COHR
P/OpInc* 10.5x 32.7x
LTM OpInc Growth 62.4% 4702.0%
3Y Avg OpInc Growth 54.1% 1521.6%
LTM Revenue Growth 20.5% 21.7%
3Y Avg Revenue Growth 19.2% 22.1%

OpInc = Operating Income

Additional Metrics To Consider

Metric CLS COHR
P/S 3.3x 3.6x
Market Cap (Current) $ 37.5 Bil $ 20.9 Bil
LTM Revenue $ 11.28 Bil $ 5.81 Bil
LTM Opinc $ 954.30 Mil $ 534.95 Mil
LTM Op Margin 8.5% 9.2%

OpInc = Operating Income

Alternate buying based on valuation, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed the S&P, and clocked >91% returns since inception.